Latest filing published 09 Mar 2024 for Elicera Therapeutics AB, €14k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jan Zetterberg: trading record in brief
Jan Zetterberg discloses dealings in 2 companies, chiefly Elicera Therapeutics AB and Elicera Therapeutics AB (publ). Over a trading history stretching from 10 June 2021 to 8 March 2024, the count stands at 5 filings.
On the market, this insider has only ever bought: 1 purchase, €5,933 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants.
The newest entry dates from 9 March 2024: a transaction of €14k, in Elicera Therapeutics AB. The clock since the last published purchase (5 July 2021) now reads 1,952 days. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The regulation allows three business days to notify a trade (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Jan Zetterberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ SEK 16.2054.3% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-122f1ae3c565878ce9b5
- 4,300 shares@ SEK 16.2023.4% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-67aae51036a040b00b9c
- 14,000 shares@ SEK 4.3022.3% of flowAktieISIN SE0015382080FI:csv-359c24db5e4e74a64adfCanonical exit: 3 Oct 2021 (T+90)
- 7,500 shares@ SEK 8.00100.0% of flowAktieISIN SE0015382080FI:csv-56660020edbce2ae4d0a
- 7,500 shares0OptionISIN SE0015988233FI:csv-b3f05d49c22ef134b4d4
5 of 5 declarations